Thermosome receives €2.7m research grant from the German Federal Ministry of Education and Research (BMBF)

Thermosome announces the final approval of a €2.7m grant from the German Ministry of Education and Research (BMBF) over the project duration of 3 years. The contribution to Thermosome is part of a larger project consortium called “TSL-LIFU”, consisting of Philips, the University Hospital of the Ludwig-Maximilians-Universitaet Munich (KUM) and the University Hospital Cologne (UHC). The consortium aims to significantly advance a novel drug-device combination for targeted delivery of cytotoxic drugs in solid tumors. Within the consortium, Thermosome and KUM will conduct further research in the area of thermosensitive drug delivery technologies and thereof derived drug candidates, leveraging Thermosome’s novel TSL technology. This technology allows the creation of drug-loaded nanocarriers – so-called Thermosomes – which release their content upon the influence of mild heat. Philips and UHC will conduct further research in the application of high intensity focused ultrasound (HIFU®) technology for hyperthermia applications at lower temperatures of about 40-42°C, so-called low-intensity focused ultrasound (LIFU). Read more (PDF)

  • On 6. April 2016